Disclaimer:

Medidex is not a provider of medical services and all information is provided for the convenience of the user. No medical decisions should be made based on the information provided on this website without first consulting a licensed healthcare provider.This website is intended for persons 18 years or older. No person under 18 should consult this website without the permission of a parent or guardian.

sonidegib

×

Overview

What is Odomzo?

ODOMZO (sonidegib) is a Smoothened (Smo) antagonist which inhibits the Hedgehog (Hh) signaling pathway.

The molecular formula for sonidegib phosphate is CH FNO• 2HPO. The molecular weight is 681.49 daltons. The chemical name is N-[6-(cis-2,6-dimethylmorpholin-4-yl)pyridine-3-yl]-2-methyl-4’-(trifluoromethoxy) [1,1’-biphenyl]-3- carboxamide diphosphate.

The molecular structure is shown below:

     

Sonidegib phosphate is a white to off-white powder. Sonidegib freebase is practically insoluble.

Each ODOMZO capsule for oral use contains 200 mg of sonidegib as the freebase (equivalent to 281 mg of diphosphate salt of sonidegib) and the following inactive ingredients: colloidal silicon dioxide, crospovidone, lactose monohydrate, magnesium stearate, poloxamer and sodium lauryl sulfate. The opaque pink hard gelatin capsule shell contains gelatin, red iron oxide, and titanium dioxide. The black printing ink contains ammonium hydroxide, black iron oxide, propylene glycol, and shellac.



What does Odomzo look like?



What are the available doses of Odomzo?

200 mg capsules (equivalent to 281 mg of diphosphate salt of sonidegib) ()

What should I talk to my health care provider before I take Odomzo?

How should I use Odomzo?

ODOMZO (sonidegib) is indicated for the treatment of adult patients with locally advanced basal cell carcinoma (BCC) that has recurred following surgery or radiation therapy, or those who are not candidates for surgery or radiation therapy.

The recommended dose of ODOMZO is 200 mg taken orally once daily on an empty stomach, at least 1 hour before or 2 hours after a meal, administered until disease progression or unacceptable toxicity .

Verify the pregnancy status of females of reproductive potential prior to initiating ODOMZO. Obtain serum creatine kinase (CK) levels and renal function tests prior to initiating ODOMZO in all patients .

If a dose of ODOMZO is missed, resume dosing with the next scheduled dose.


What interacts with Odomzo?

Sorry No Records found


What are the warnings of Odomzo?

Sorry No Records found


What are the precautions of Odomzo?

Sorry No Records found


What are the side effects of Odomzo?

Sorry No records found


What should I look out for while using Odomzo?

None.


What might happen if I take too much Odomzo?

There are no recommendations regarding management of overdosage.


How should I store and handle Odomzo?

Each ODOMZO capsule has an opaque pink color with ‘SONIDEGIB 200MG’ printed on the capsule body and ‘NVR’ printed on the cap in black ink. ODOMZO capsules are supplied as follows:Bottle of 30 capsules               NDC 47335-303-83Store at 25°C (77°F); excursions permitted to 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature].Each ODOMZO capsule has an opaque pink color with ‘SONIDEGIB 200MG’ printed on the capsule body and ‘NVR’ printed on the cap in black ink. ODOMZO capsules are supplied as follows:Bottle of 30 capsules               NDC 47335-303-83Store at 25°C (77°F); excursions permitted to 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature].Each ODOMZO capsule has an opaque pink color with ‘SONIDEGIB 200MG’ printed on the capsule body and ‘NVR’ printed on the cap in black ink. ODOMZO capsules are supplied as follows:Bottle of 30 capsules               NDC 47335-303-83Store at 25°C (77°F); excursions permitted to 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature].